Third Harmonic Bio, Inc.
THRD
Price:
$13.005
Market Cap:
$534.47M
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-09-14
Stock Exchange
NASDAQ
Ticker
THRD
The ROE as of September 2024 (TTM) for Third Harmonic Bio, Inc. (THRD) is -6.80%
According to Third Harmonic Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -6.80%. This represents a change of 288.38% compared to the average of -1.75% of the last 4 quarters.
Third Harmonic Bio, Inc. (THRD) Historical ROE (quarterly & annually)
How has THRD ROE performed in the past?
The mean historical ROE of Third Harmonic Bio, Inc. over the last ten years is 27.17%. The current -6.80% ROE has changed -125.03% with respect to the historical average. Over the past ten years (40 quarters), THRD's ROE was at its highest in in the December 2021 quarter at 33.79%. The ROE was at its lowest in in the March 2021 quarter at -942.40%.
Average
27.17%
Median
25.97%
Minimum
-13.04%
Maximum
69.77%
Third Harmonic Bio, Inc. (THRD) ROE by Quarter and Year
Discovering the peaks and valleys of Third Harmonic Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 69.77%
Minimum Annual Increase = -120.58%
Minimum Annual ROE = -13.04%
| Year | ROE | Change |
|---|---|---|
| 2023 | -11.46% | -12.19% |
| 2022 | -13.04% | -120.58% |
| 2021 | 63.39% | -9.13% |
Third Harmonic Bio, Inc. (THRD) Average ROE
How has THRD ROE performed in the past?
The current ROE of Third Harmonic Bio, Inc. (THRD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.96%
5-year avg
27.17%
10-year avg
27.17%
Third Harmonic Bio, Inc. (THRD) ROE vs. Peers
How is THRD’s ROE compared to its peers?
Third Harmonic Bio, Inc.’s ROE is greater than Sensei Biotherapeutics, Inc. (-48.14%), greater than NextCure, Inc. (-57.63%), greater than Nuvation Bio Inc. (-98.79%), greater than Graphite Bio, Inc. (-57.96%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Rallybio Corporation (-74.08%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Enochian Biosciences, Inc. (-70.62%), greater than Revolution Medicines, Inc. (-34.57%), greater than Passage Bio, Inc. (-70.73%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Eliem Therapeutics, Inc. (-47.03%),
| Company | ROE | Market cap |
|---|---|---|
| -48.14% | $11.57M | |
| -57.63% | $36.09M | |
| -98.79% | $762.11M | |
| -57.96% | $185.19M | |
| -35.28% | $223.97M | |
| -28.37% | $979.22M | |
| -28.01% | $1.59B | |
| -74.08% | $46.89M | |
| -70.40% | $359.95M | |
| -21.96% | $78.05M | |
| -70.62% | $45.38M | |
| -34.57% | $7.39B | |
| -70.73% | $45.87M | |
| -48.25% | $93.52M | |
| -47.31% | $263.26M | |
| -47.03% | $550.56M |
Build a custom stock screener for Third Harmonic Bio, Inc. (THRD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Third Harmonic Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Third Harmonic Bio, Inc. (THRD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Third Harmonic Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Third Harmonic Bio, Inc.'s ROE?
How is the ROE calculated for Third Harmonic Bio, Inc. (THRD)?
What is the highest ROE for Third Harmonic Bio, Inc. (THRD)?
What is the 3-year average ROE for Third Harmonic Bio, Inc. (THRD)?
What is the 5-year average ROE for Third Harmonic Bio, Inc. (THRD)?
How does the current ROE for Third Harmonic Bio, Inc. (THRD) compare to its historical average?